Skip to main content

Home/ Dr. Goodyear/ Group items tagged opioid growth factor

Rss Feed Group items tagged

Nathan Goodyear

Low-dose naltrexone targets the opioid growth factor-opioid growth factor receptor path... - 0 views

  •  
    low-dose naltrexone (NLD) is shown to inhibit growth in vivo.  This is important as it has implications in cancer therapies.  This study found a greater benefit with LDN and exogenous opioid growth factor (OGF).
Nathan Goodyear

Low-dose naltrexone targets the opioid growth factor-opioid growth factor receptor path... - 0 views

  •  
    LDN inhibits cell proliferation through increased opioid growth factor and receptor translation.
Nathan Goodyear

Opioid growth factor and the treatment of human pancreatic cancer: A review - 0 views

  •  
    Review of Opioid Growth Factor inhibition of cancer growth via inhibition in cell cycle.
Nathan Goodyear

Low-dose naltrexone (LDN): Tricking the body to heal itself - 0 views

  •  
    synopsis of a previously posted article on LDN and OGF in the potential use in cancer.
Nathan Goodyear

Opioid growth factor - opioid growth factor receptor axis inhibits proliferation of tri... - 0 views

  •  
    Peptide therapy effective in inhibits proliferation in TNBC.
1 - 8 of 8
Showing 20 items per page